Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Life Sciences
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing
Resources
Scientific Publications
Oct 9, 2024
Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi-site retrospective study
Thought Leadership
Oct 4, 2024
Understanding Model-Informed Precision Dosing (MIPD) and Bayesian Statistics in Pharmacy
Thought Leadership
Sep 18, 2024
How well do AUC24 estimates and trough estimates correlate in vancomycin?
Thought Leadership
Sep 18, 2024
Overcoming barriers to beta-lactam TDM through Bayesian model-informed precision dosing
Thought Leadership
Sep 11, 2024
Choosing the right model for your patient: An introduction to InsightRX Gemini
Thought Leadership
Sep 10, 2024
Streamlining Patient Care with EHR Integration
Thought Leadership
Jun 28, 2024
AUC Monitoring for Vancomycin: Comparing Estimation Methods
White Papers
Jun 21, 2024
InsightRX White Paper: Implementation Best Practices
Thought Leadership
Jun 13, 2024
Recognizing the value of therapeutic drug monitoring for beta-lactam antibiotics
1
2
3
4
5
